当前位置:首页 - 行情中心 - 葵花药业(002737) - 财务分析 - 现金流量表

葵花药业

(002737)

  

流通市值:104.24亿  总市值:104.24亿
流通股本:5.84亿   总股本:5.84亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,506,428,102.712,052,345,626.641,515,811,304.346,164,389,417.61
收到其他与经营活动有关的现金103,796,244.8870,444,075.7740,744,852.2133,400,461.2
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,610,224,347.592,122,789,702.411,556,556,156.546,297,789,878.81
购买商品、接受劳务支付的现金1,362,767,421.21,092,539,261.05707,694,982.682,455,415,914.62
支付给职工以及为职工支付的现金500,063,667.36354,906,651.31170,036,175.78611,932,237.04
支付的各项税费422,334,340.22299,950,904.73176,112,512.09723,412,942.58
支付其他与经营活动有关的现金724,232,049.83517,551,360.21298,421,913.041,617,340,889.41
经营活动现金流出的平衡项目0000
经营活动现金流出小计3,009,397,478.612,264,948,177.31,352,265,583.595,408,101,983.65
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-399,173,131.02-142,158,474.89204,290,572.95889,687,895.16
二、投资活动产生的现金流量:
收回投资收到的现金3,400,000,0002,300,000,0001,000,000,0002,270,000,000
取得投资收益收到的现金31,159,586.726,882,905.3420,817,239.7333,612,581.28
处置固定资产、无形资产和其他长期资产收回的现金净额1,110,99527,460-4,051,114.91
投资活动现金流入的平衡项目0000
投资活动现金流入小计3,432,270,581.72,326,910,365.341,020,817,239.732,307,663,696.19
购建固定资产、无形资产和其他长期资产支付的现金77,469,735.4450,833,049.4313,985,381.42149,164,927.9
投资支付的现金3,100,000,0001,800,000,000-2,122,300,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计3,177,469,735.441,850,833,049.4313,985,381.422,271,464,927.9
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额254,800,846.26476,077,315.911,006,831,858.3136,198,768.29
三、筹资活动产生的现金流量:
取得借款收到的现金---10,000,000
收到其他与筹资活动有关的现金---4,432,734.26
筹资活动现金流入平衡项目---0
筹资活动现金流入小计---14,432,734.26
偿还债务支付的现金10,000,00010,000,000-420,000,000
分配股利、利润或偿付利息支付的现金925,333,602.58902,265,623.6892,263.9626,791,868.06
其中:子公司支付给少数股东的股利、利润40,631,072.225,780,057.76-38,282,840.25
支付其他与筹资活动有关的现金7,466,326.513,408,572.01923,528.666,471,110.21
筹资活动现金流出平衡项目0000
筹资活动现金流出小计942,799,929.09915,674,195.691,015,792.561,053,262,978.27
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-942,799,929.09-915,674,195.69-1,015,792.56-1,038,830,244.01
四、汇率变动对现金及现金等价物的影响-536,068.85-103,401.53-134,377.44231,536.17
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,087,708,282.7-581,858,756.21,209,972,261.26-112,712,044.39
加:期初现金及现金等价物余额2,285,705,205.892,285,705,205.892,285,705,205.892,398,417,250.28
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,197,996,923.191,703,846,449.693,495,677,467.152,285,705,205.89
补充资料:
净利润-516,283,951.6-1,164,938,619.77
资产减值准备-8,913,068.11--1,574,895.25
固定资产和投资性房地产折旧-72,885,163.02-145,333,662.22
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-72,885,163.02-145,333,662.22
无形资产摊销-12,916,214.47-29,487,172.38
长期待摊费用摊销-1,439,665.37-2,047,629.88
处置固定资产、无形资产和其他长期资产的损失-94.21--3,230,614.33
固定资产报废损失---482,198.61
公允价值变动损失-12,288,734.9-16,388,444.95
财务费用-424,913.67-6,051,674.96
投资损失--9,230,674.13--46,963,767.59
递延所得税-8,508,116.73--4,690,346.18
其中:递延所得税资产减少-9,512,539.02--2,408,911.86
递延所得税负债增加--1,004,422.29--2,281,434.32
存货的减少--32,096,126.95--241,473,064.3
经营性应收项目的减少--533,977,872.59-77,043,891.06
经营性应付项目的增加--208,725,399.45--286,200,476.59
其他-5,212,523.34-25,664,565.81
现金的期末余额-1,703,846,449.69-2,285,705,205.89
减:现金的期初余额-2,285,705,205.89-2,398,417,250.28
公告日期2024-10-292024-08-282024-04-262024-04-26
审计意见(境内)标准无保留意见
TOP↑